VYOME HOLDINGS, INC. Payments to Acquire Productive Assets
VYOME HOLDINGS, INC. (HIND) reported Payments to Acquire Productive Assets of $43.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2025-04-04
- VYOME HOLDINGS, INC. payments to acquire productive assets for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. payments to acquire productive assets for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. payments to acquire productive assets for the quarter ending 2023-06-30 was $36.00K, a 200.00% increase year-over-year.
- VYOME HOLDINGS, INC. payments to acquire productive assets for the quarter ending 2023-03-31 was $7.00K, a 0.00% change year-over-year.
- VYOME HOLDINGS, INC. payments to acquire productive assets for fiscal 2023 was $43.00K, a 67.18% decline from fiscal 2022.
- VYOME HOLDINGS, INC. payments to acquire productive assets for fiscal 2022 was $131.00K, a 62.78% decline from fiscal 2021.
- VYOME HOLDINGS, INC. payments to acquire productive assets for fiscal 2021 was $352.00K.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $0.00 derived: sum of 2 quarters · filed 2025-04-04 | $36.00K derived: sum of 3 quarters · filed 2025-04-04 | $43.00K 10-K · filed 2025-04-04 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $36.00K derived: sum of 2 quarters · filed 2024-11-14 | $43.00K 10-Q · filed 2024-11-14 | $122.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $43.00K 10-Q · filed 2024-08-14 | $122.00K derived: sum of 3 quarters · filed 2024-08-14 | $155.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-15 | $86.00K derived: sum of 2 quarters · filed 2024-05-15 | $119.00K derived: sum of 3 quarters · filed 2024-05-15 | $131.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $112.00K derived: sum of 2 quarters · filed 2024-04-01 | $124.00K derived: sum of 3 quarters · filed 2024-04-01 | $131.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $45.00K derived: sum of 2 quarters · filed 2023-11-09 | $52.00K 10-Q · filed 2023-11-09 | $119.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $19.00K 10-Q · filed 2023-08-07 | $86.00K derived: sum of 3 quarters · filed 2023-08-07 | $175.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-15 | $74.00K derived: sum of 2 quarters · filed 2023-05-15 | $163.00K derived: sum of 3 quarters · filed 2023-05-15 | $240.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $156.00K derived: sum of 2 quarters · filed 2023-04-17 | $233.00K derived: sum of 3 quarters · filed 2023-04-17 | $352.00K 10-K · filed 2023-04-17 |
| 2021-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $166.00K derived: sum of 2 quarters · filed 2022-11-14 | $285.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $196.00K 10-Q · filed 2022-08-19 | ||
| 2021-03-31 | $119.00K 10-Q · filed 2022-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |